Literature DB >> 9671972

Calcineurin inhibition prevents calpain-mediated proteolysis of tau in differentiated PC12 cells.

H Q Xie1, G V Johnson.   

Abstract

The effects of calcium influx on tau levels and phosphorylation were examined in differentiated PC12 cells. Maitotoxin-induced calcium influx resulted in time- and concentration-dependent tau dephosphorylation and degradation. Incubation of PC12 cells with a membrane-permeable calpain inhibitor blocked maitotoxin-induced tau degradation, suggesting the involvement of calpain in calcium-stimulated tau turnover. Okadaic acid or the calcineurin inhibitor FK520 partially inhibited maitotoxin-induced tau dephosphorylation at the Tau-1 epitope, indicating both phosphatase 2A/1 and calcineurin were involved. In addition, FK520, but not okadaic acid, blocked the maitotoxin-induced tau degradation, demonstrating that dephosphorylation of specific tau epitopes by was essential for calpain-mediated tau degradation. Moreover, maitotoxin effects were likely independent of tau association with microtubules because maitotoxin induced tau degradation and dephosphorylation in the presence of either nocodazole or taxol. These data provide evidence that calpain is involved in tau turnover in situ and calcineurin plays an important role in modulating tau susceptibility to calpain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9671972     DOI: 10.1002/(SICI)1097-4547(19980715)53:2<153::AID-JNR4>3.0.CO;2-6

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  14 in total

1.  The rate of Tau synthesis is differentially regulated during postnatal development in mouse cerebellum.

Authors:  G J Vilá-Ortiz; T A Santa-Coloma; H Carminatti; M Radrizzani
Journal:  Cell Mol Neurobiol       Date:  2001-10       Impact factor: 5.046

2.  Ethanol enhances tau accumulation in neuroblastoma cells that inducibly express tau.

Authors:  Tania F Gendron; Sharon McCartney; Ena Causevic; Li-Wen Ko; Shu-Hui Yen
Journal:  Neurosci Lett       Date:  2008-07-24       Impact factor: 3.046

Review 3.  Tear me down: role of calpain in the development of cardiac ventricular hypertrophy.

Authors:  Cam Patterson; Andrea L Portbury; Jonathan C Schisler; Monte S Willis
Journal:  Circ Res       Date:  2011-08-05       Impact factor: 17.367

4.  Ischemic preconditioning attenuates of ischemia-induced degradation of spectrin and tau: implications for ischemic tolerance.

Authors:  Takayuki Nakajima; Syoichi Ochi; Chika Oda; Maki Ishii; Kazushige Ogawa
Journal:  Neurol Sci       Date:  2010-07-02       Impact factor: 3.307

5.  Phosphorylation inhibits turnover of the tau protein by the proteasome: influence of RCAN1 and oxidative stress.

Authors:  Diana Poppek; Susi Keck; Gennady Ermak; Tobias Jung; Alexandra Stolzing; Oliver Ullrich; Kelvin J A Davies; Tilman Grune
Journal:  Biochem J       Date:  2006-12-15       Impact factor: 3.857

6.  Do RCAN1 proteins link chronic stress with neurodegeneration?

Authors:  Gennady Ermak; Melanie A Pritchard; Sladjana Dronjak; Brenda Niu; Kelvin J A Davies
Journal:  FASEB J       Date:  2011-06-16       Impact factor: 5.191

Review 7.  The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states.

Authors:  P W Vanderklish; B A Bahr
Journal:  Int J Exp Pathol       Date:  2000-10       Impact factor: 1.925

Review 8.  Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration.

Authors:  P S Vosler; C S Brennan; J Chen
Journal:  Mol Neurobiol       Date:  2008-08-07       Impact factor: 5.590

9.  Calpain inhibitors: a treatment for Alzheimer's disease.

Authors:  Gabriella Di Rosa; Tatjana Odrijin; Ralph A Nixon; Ottavio Arancio
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

10.  Dephosphorylation of tau protein by calcineurin triturated into neural living cells.

Authors:  Qun Wei; Max Holzer; Martina K Brueckner; Yu Liu; Thomas Arendt
Journal:  Cell Mol Neurobiol       Date:  2002-02       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.